EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

B cell–based therapy produces antibodies that inhibit glioblastoma growth

Si Wang, Brandyn A Castro, Joshua L Katz, Victor Arrieta, Hinda Najem, Gustavo I Vazquez-Cervantes, Hanxiao Wan, Ian E Olson, David Hou, Mark Dapash, Leah K Billingham, Tzu-Yi Chia und 16 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci177384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Si Wang und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansAnimalsMiceCell Line, TumorB-LymphocytesTumor MicroenvironmentCell MovementCancer VaccinesFemaleImmunotherapyAntibodies, NeoplasmMale

Stichwörter der Autor:innen

Brain cancerCancer immunotherapyExtracellular matrixImmunologyOncology

Substanzen

Cancer VaccinesAntibodies, Neoplasm

Autor:innen und Institutionen

  • Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Lou and Jean Malnati Brain Tumor Institute, Chicago, Illinois, USA.
  • Department of Neurological Surgery, University of Chicago Medicine, Chicago, Illinois, USA.
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
  • Department of Medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • Cancer Research Institute
  • National Institute of Neurological Diseases
  • National Institutes of Health

Zitieren

APA

Wang, S., Castro, B. A., Katz, J. L., Arrieta, V., Najem, H., Vazquez-Cervantes, G. I., Wan, H., Olson, I. E., Hou, D., Dapash, M., Billingham, L. K., Chia, T. Y., Wei, C., Rashidi, A., Platanias, L. C., McCortney, K., Horbinski, C. M., Stupp, R., Zhang, P., …, & Lee-Chang, C. (2024). B cell–based therapy produces antibodies that inhibit glioblastoma growth. Journal of Clinical Investigation. https://doi.org/10.1172/jci177384

Vancouver

Wang S, Castro BA, Katz JL, Arrieta V, Najem H, Vazquez-Cervantes GI, et al. B cell–based therapy produces antibodies that inhibit glioblastoma growth. Journal of Clinical Investigation. 2024. doi:10.1172/jci177384

BibTeX
@article{Wang2024,
  author = {Wang, Si and Castro, Brandyn A and Katz, Joshua L and Arrieta, Victor and Najem, Hinda and Vazquez-Cervantes, Gustavo I and Wan, Hanxiao and Olson, Ian E and Hou, David and Dapash, Mark and Billingham, Leah K and Chia, Tzu-Yi and Wei, Chao and Rashidi, Aida and Platanias, Leonidas C and McCortney, Kathleen and Horbinski, Craig M and Stupp, Roger and Zhang, Peng and Ahmed, Atique U and Sonabend, Adam M and Heimberger, Amy B and Lesniak, Maciej S and Riviere-Cazaux, Cécile and Burns, Terry and Miska, Jason and Fischietti, Mariafausta and Lee-Chang, Catalina},
  title = {B cell–based therapy produces antibodies that inhibit glioblastoma growth},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci177384}
}
Kostenlos starten →